AstraZeneca drug fails main goal of late-stage amyloidosis study
ReutersJul 16, 2025 6:13 AM
July 16 (Reuters) - AstraZeneca AZN.L on Wednesday said that its experimental drug anselamimab did not meet the main goal of a late-stage study for the treatment of AL amyloidosis, a rare condition that causes a buildup of protein deposits in the body.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
XRP Price Skyrockets—Is a $4 Target Now Within Reach?
XRP price started a fresh increase and surged above the $3.350 zone. The price is now consolidating gains and might continue to rise above the $3.60 zone.NewsBTC
19 hours ago
TSMC Q2 FY2025 Earnings Review: AI Drives Record Growth Amid Currency, Geopolitical Risks
TradingKey - TSMC (NYSE: TSM) reported its Q2 FY2025 earnings on July 17, 2025, delivering a strong performance that exceeded expectations, driven by surging AI demand and advanced technology adoption. Following the earnings release, TSMC’s stock in the U.S. market surged 4.36% in after-hours...TradingKey
Thu, Jul 17
Bitcoin Price Forecast: Trends and Investment Outlook from 2025 to 2030
From $0.01 in 2009 to $120,000+ in 2025, Bitcoin has evolved from obscurity to a globally recognized financial asset. While institutions and governments increasingly embrace it, investors must remain vigilant against volatility, security risks, and scams.TradingKey
Wed, Jul 16
Japan June Inflation Preview: Expected to Ease but Remain Above Target, Providing Short-Term Support for the Yen
TradingKey - Japan is set to release its June inflation data on 18 July 2025, with market consensus forecasting that the National CPI (excluding fresh food) will ease to 3.3% year-on-year from 3.7% in May.TradingKey
Wed, Jul 16
Bitcoin Volatility Hits Bull Cycle Low – Bollinger Bands Signal Potential Breakout
Bitcoin has remained in a tight consolidation range below its all-time high of $112,000 since late May, frustrating both bulls and bears. Despite multiple failed breakout attempts, BTC has held key demand zones above critical support levels, suggesting strong underlying strength.Bitcoinist
Wed, Jul 9
Tradingkey
